COVID-19

The US has reached the 50% mark for vaccinations for adults.

The company expects to file for FDA authorization for the 12-17 year old population in June.

A large proportion of IBS-C patients did not seek health care during the COVID-19 pandemic despite symptoms.

COVID-19 patients with liver injuries are at a higher risk of mortality or lengthier hospital stays.

An expert discussion on climate change and air pollution effects on communities, including increased COVID-19 rates.

Early data suggests vaccines are effective against B.1.617.2 variant first discovered in India.

The anticoagulant did not improve clinical outcomes when compared with prophylactic anticoagulation.

A cardiologist and wellness expert discusses new findings showing more than one-third of her peers were burnt out from experiences during the pandemic.

DARE-19 data show a slight improvement in outcomes among hospitalized COVID-19 patients receiving the SGLT-2 inhibitor—showing the cardiovascular drug class is safe in patients with the pandemic virus.

Vaccinated individuals no longer need to wear masks indoors in accordance with CDC guidance.

Data show a nearly 30% reduction in individuals filling naloxone prescriptions at the start of COVID-19 pandemic, with no significant recovery observed.

Prescription rates of buprenorphine and opioid analgesics for OUD fell during the COVID-19 pandemic for new patients, but existing treatment was not affected.

More than 3000 people per day in India have died of COVID-19 since April 28.

Meredith McCormack, MD discusses consequences of high air pollution levels in the United States found in the 2021 American Lung Association State of the Air Report.

Dr. Todd Hutton gives tips for how to best handle the ongoing mental health crisis.

A recent JAMA study shows a decrease in suicide deaths between 2019-2020, despite a 17% overall increase in mortality.

The companies announce plans to submit a Biologics License Agreement for the mRNA-based vaccine.

New data show immunosuppressant treatment did not increase susceptibility to or severity of COVID-19 in patients with immune-mediated inflammatory disease

Patients with nAMD, DME, and RVO received fewer intravitreal injections between pre- and post-lockdown periods.

Nearly a third of the US population has been fully vaccinated.

Dr. Joshua Morganstein discusses the psychological impacts disasters can have on individuals and how the COVID-19 pandemic might be different than other disasters.

The US will send unused vaccines to India to help combat the growing pandemic.

Esther Freeman, MD, PhD, discusses the most frequent cutaneous presentations associated with vaccination.

A study out of Boston observes little to no difference in previous biologic prescription and worsened odds of infection nor death during the pandemic.

Esther Freeman, MD, PhD, talks about the various levels of dermatologic severity associated with COVID-19.